Metabolism


Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
-
B1788 MevastatinTarget: HMG-CoA ReductasesSummary: HMG-CoA reductase inhibitor -
B1123 RosuvastatinSummary: Competitive inhibitor of HMG-CoA reductase -
B1154 Oxonic acid potassium saltSummary: Uricase inhibitor -
B1240 (+)-KetoconazoleSummary: Potent inhibitor of cytochrome P450c17 -
B1124 Pitavastatin2 CitationSummary: HMG-CoA reductase inhibitor -
B1125 PravastatinSummary: HMG-CoA reductase inhibitor against sterol synthesis -
B1165 Pimobendan hydrochlorideSummary: Selective inhibitor of PDE3 -
B1676 Benzoic AcidSummary: Organic aromatic monocarboxylic acid -
B1727 DibenzothiopheneSummary: Organically synthesized intermediate -
B1871 ZoxazolamineSummary: Uricosuric and muscle relaxant
